Arrowhead Pharmaceuticals
ARWR
#1767
Rank
A$17.20 B
Marketcap
A$122.14
Share price
-1.64%
Change (1 day)
406.15%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2026 (TTM): -A$0.24 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are A$0.62 Billion. In 2025 the company made an earning of A$0.49 Billion, an increase over its 2024 earnings that were of -A$0.86 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.24 Billion-147.84%
2025 A$0.49 B-157.5%
2024 -A$0.86 Billion112.45%
2023 -A$0.41 Billion87.79%
2022 -A$0.22 Billion-20.1%
2021 -A$0.27 Billion67.59%
2020 -A$0.17 Billion-347.53%
2019 A$64.95 M-245.59%
2018 -A$44.62 Million-13.17%
2017 -A$51.39 Million-52.28%
2016 -A$0.11 Billion-16.57%
2015 -A$0.13 Billion30.32%
2014 -A$99.04 Million171.62%
2013 -A$36.47 Million16.56%
2012 -A$31.28 Million107.53%
2011 -A$15.08 Million
2008 -A$53.1 Million-8.07%
2007 -A$57.76 Million70.37%
2006 -A$33.9 Million122.51%
2005 -A$15.24 Million147.41%
2004 -A$6.16 Million2002.28%
2003 -A$0.3 Million-85.61%
2002 -A$2.04 Million1371.97%
2001 -A$0.14 Million-13.45%
2000 -A$0.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.17 B-16,353.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-A$4.46 Billion 1,847.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.27 B-219.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion-26.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.24 B-644.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-A$0.13 Billion-45.44%๐Ÿ‡บ๐Ÿ‡ธ USA